OraSure's OMNIgene®·ORAL Collection Device Receives FDA Emergency Use Authorization for SARS CoV-2GlobeNewsWire • 10/19/20
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to Quadrant Biosciences Inc. for COVID-19 TestGlobeNewsWire • 09/24/20
OraSure’s ORAcollect®·RNA Device Included in EUA Granted to MiraDx Inc. for SARS-CoV-2 TestGlobeNewsWire • 09/03/20
OraSure Technologies, Inc. (OSUR) CEO Steve Tang on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
OraSure Technologies (OSUR) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/05/20
OraSure Technologies, Inc. Announces 2020 Second Quarter Financial Results and Update on COVID-19 Testing ProgramsGlobeNewsWire • 08/05/20
OraSure’s OMNIgene®·ORAL Device Included in EUA Granted to Clinical Reference Laboratory for Self-Collected SARS-CoV-2 Saliva TestGlobeNewsWire • 07/31/20
Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to DeclineZacks Investment Research • 07/29/20
OraSure Technologies to Hold Second Quarter 2020 Earnings Conference Call on August 5th, 2020GlobeNewsWire • 07/22/20
OraSure’s DNA Genotek Subsidiary Unveils First In-Home Self-Collection Device for MetabolomicsGlobeNewsWire • 06/17/20
Metabolon, Inc. and DNA Genotek Collaborate on First Ambient-Temperature Microbiome Sampling Solution for MetabolomicsPRNewsWire • 06/17/20
OraSure Technologies Receives BARDA Funding for Coronavirus Antibody ELISA Using Oral Fluid SamplesGlobeNewsWire • 06/10/20
OraSure’s Oragene®•Dx included in EUA allowing at-home saliva collection for use with Phosphorus SARS-CoV-2 testGlobeNewsWire • 06/08/20
OraSure Technologies, Inc. Announces Exercise of Option to Purchase Additional Shares of Common StockGlobeNewsWire • 06/04/20
OraSure Technologies, Inc. Announces Proposed Public Offering of Common StockGlobeNewsWire • 06/01/20